Cargando…
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
Aim: This study aimed to assess the potential effect of prior antithrombotic medication for thrombolysis in an unknown onset stroke. Methods: This was a predefined sub-analysis of the THAWS trial. Stroke patients with a time last known well >4.5 h who had a DWI-fluid-attenuated inversion recovery mi...
Autores principales: | Koga, Masatoshi, Inoue, Manabu, Miwa, Kaori, Yoshimura, Sohei, Fukuda-Doi, Mayumi, Aoki, Junya, Asakura, Koko, Kanzawa, Takao, Ohtaki, Masafumi, Kamiyama, Kenji, Yakushiji, Yusuke, Igarashi, Shuichi, Doijiri, Ryosuke, Ito, Yasuhiro, Takagi, Yasushi, Sasaki, Makoto, Kitazono, Takanari, Kimura, Kazumi, Minematsu, Kazuo, Yamamoto, Haruko, Toyoda, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899700/ https://www.ncbi.nlm.nih.gov/pubmed/35197420 http://dx.doi.org/10.5551/jat.63337 |
Ejemplares similares
-
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020) -
THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
por: Koga, Masatoshi, et al.
Publicado: (2014) -
Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022) -
Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2
por: Tanaka, Kanta, et al.
Publicado: (2022) -
Is the rapid sequence induction possible with 0.6 mg/kg rocuronium in pediatric patient?
por: Lee, Sang Kyu, et al.
Publicado: (2010)